Fig. 4

Kaplan-Meier analysis of treatment persistence with octreotide or lanreotide, patients with 180-day washout period (n = 663). Numbers above axis indicate subjects at risk. Survival indicates probability of patients continuing treatment. LAN lanreotide; OCT octreotide